Key PointsQuestionAre there clinical benefits associated with real-time continuous glucose monitoring (CGM) among patients with insulin-treated diabetes? FindingsIn this retrospective cohort study in a usual care setting that included 5673 patients with type 1 diabetes and 36 080 patients with type 2 diabetes, use of real-time CGM compared with nonuse was associated with significantly lower hemoglobin A1c (difference, −0.40%) and lower rates of emergency department visits or hospitalizations for hypoglycemia (difference, −2.73%) but no significant difference for rates of emergency department visits or hospitalizations for hyperglycemia or for other reasons. MeaningAmong patients selected by physicians for real-time continuous glucose monitoring use was associated with better glycemic control and lower rates of hypoglycemia.
JAMA – American Medical Association
Published: Jun 8, 2021